Has Solomon Rojhani, MD received payments from drug or device companies?

Yes. Drug and device makers reported $17,057 in general payments to Solomon Rojhani, MD across 371 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Solomon Rojhani, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Solomon Rojhani, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Solomon Rojhani, MD

Physical Medicine & Rehabilitation · Beverly Hills, CANPI 1033452750

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,415 of the $17,057 with a category attached, or 72.8%. Medtronic accounts for 85.7% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $7,403 and has fallen 89.9% since, to $744 in 2025. Among physical medicine & rehabilitation clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,057in general payments, 2019–2025

Across 371 payments — averaging $45.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$15K
Boston Scientific$943
Nalu Medical, Inc.$564
Abbott$343
Nevro Corp.$194
Pfizer$96
plus $306 from 10 others

$460in research payments, 2019–2025

Across 1 payment — averaging $460.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$460

What the payments were for

Speaking & faculty fees$3,57521%
Travel & lodging$1,0686%
Food & beverage$12,41573%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	304	$14,612
Boston Scientific	18	$943
Nalu Medical, Inc.	16	$564
Abbott	13	$343
Nevro Corp.	6	$194
Pfizer	4	$96
Innovation Technologies Inc	1	$94
Johnson & Johnson	1	$44
Vertos Medical, Inc.	1	$43
Vertiflex, Inc.	1	$21
Amgen	1	$20
Novartis	1	$20
Scilex Pharmaceuticals Inc.	1	$18
Stimwave Technologies Incorporated	1	$16
AbbVie	1	$15
Bioventus LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTELLIS ADAPTIVESTIM$3,116
INTELLIS$1,926
SYNCHROMEDII$1,810
GENERAL PAIN MANAGEMENT$498
RESTORE$295
SPECIFY$276
ADAPTIVESTIM$193
Accurian$169
VANTA ADAPTIVESTIM$159
Nalu Neurostimulation System$142
Proclaim Family of SCS IPGs$140
Senza Spinal Cord Stimulation System$131
Vanta$128

How this compares

$17,057 in reported general payments places this provider in the 95th percentile of 830 physical medicine & rehabilitation providers in California.

See all physical medicine & rehabilitation providers in California →

Medicare billing

Part B allowed, 2024

$360,807

Medicare patients

710

Services billed

3,968

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	228	$3,488
Lidocaine	26	$2,662
Diclofenac Sodium	17	$2,435
Pregabalin	80	$2,319
Gabapentin	115	$1,128
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	87	$892
Methocarbamol	19	$602
Tramadol Hcl	100	$527
Oxycodone Hcl	34	$402
Tizanidine Hcl	53	$322
Cyclobenzaprine Hcl	46	$312
Baclofen	18	$243
Ibuprofen	25	$191
Meloxicam	36	$120

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Beverly Hills

Ziyad AyyoubParamount$322K
Pratik GandhiAnaheim$122K
Mary OatesSanta Maria$115K
Kevin BarretteSan Francisco$84K
Steven SampsonLos Angeles$63K
Jeffrey ChenSan Diego$59K
Nanette JoyceSacramento$56K
Amir RahnavardMonterey$49K
Kyle RyanSan Diego$39K
Kyle YangLos Angeles$39K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →